NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies

par Hilal S. Khalil, Simon P. Langdon, Ibrahim H. Kankia, James Bown, Yusuf Y. Deeni
Publié 2016-01-01

Systems Analysis of Drug-Induced Receptor Tyrosine Kinase Reprogramming Following Targeted Mono- and Combination Anti-Cancer Therapy

par Alexey Goltsov, Yusuf Deeni, Hilal S. Khalil, Tero Soininen, Stylianos Kyriakidis, Huizhong Hu, Simon P. Langdon, David J. Harrison, James Bown
Publié 2014-06-01

Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer

par James Meehan, Mark Gray, Mark Gray, Carlos Martínez-Pérez, Carlos Martínez-Pérez, Charlene Kay, Lisa Y. Pang, Jennifer A. Fraser, Amy V. Poole, Ian H. Kunkler, Simon P. Langdon, David Argyle, Arran K. Turnbull, Arran K. Turnbull
Publié 2020-04-01